So fortunate to have the opportunity to cycle through Valley Forge on the way to the OR

Incredible summary of an exceptional human. These lessons imparted in all of us fortunate enough to have known Dr Canning ensure that his impact on our world will continue

⁦⁦David J. Sas⁩ dropping knowledge at #IPNA 2022. Best slide on stone risk I’ve seen. Not a dichotomy. It’s a spectrum of risk. Need to discover the impact of the exposome on genetic susceptibility to understand changing epidemiology and develop new therapeutics. ⁦

Heat and human health. Stones one of the many expected consequences of climate change…along with catastrophic storms, infectious diseases, displacement of vulnerable communities.

Patient-related factors, rather than procedure-related factors, are predictive of severe pain interference. Psychosocial factors like depression predict greater pain interference. #WCET22 #KidneyStones Gregory Tasian, MD, MSc, MSCE Hunter Wessells Jonathan Harper MD Chuck Scales

Interested in biomarker research in patients with #stents for treating #KidneyStones? The USDRN has ~23,000 specimens linked to 300 participants in the STENTS study, which are available for collaborative research. #WCET22 #WCET2022 Dirk Lange Gregory Tasian, MD, MSc, MSCE Jonathan Harper MD

We are honored to be ranked as one of the top research institutions in the United States in a new report by Heartland Forward! This recognition is particularly meaningful as we celebrate #CHOPResearch100. Read more in this article in Philadelphia Business Journal. bit.ly/3fnBSrI

Adios

#MCIBRE via Premier League premierleague.com/match/75065

@NaeemBhojani7 Fadl Hamouche MD, FRCSC Thomas Chi Amy Krambeck Khurshid Ghani Olivier Traxer Brian Eisner Dr. Ben Chew Sero Roger Sur Great ? Short answer from our focus groups - some do. Longer answer - unsure if this is a means to an end or an end in itself. Patient-centered surgical outcomes development is an area ripe for stakeholder engagement. Kidney Stone Engagement Core The Patient-Centered Outcomes Research Institute Gregory Tasian, MD, MSc, MSCE

Looking forward to Dr Nicolas Fernandez presenting on surgeon variation in the PKIDS network. #surgicaldecisionmaking Pediatrics Podium Session 1. #AUA23 PKIDS Gregory Tasian, MD, MSc, MSCE

It takes a crowd! ⁦Maria Antony⁩ reporting that moderate intra-rater reliability in classifying urodynamics. Improved by multiple raters.

Will clarity arise from uncertainty? Join us to find out!

⁦Jonathan Ellison (he/him/his)⁩ sharing patient generated research themes from PRACTICAL. need the patient voice to determine what new knowledge is needed!

UCSF at #AUA23 💪🏻 SamWashUro Thomas Chi Gregory Tasian, MD, MSc, MSCE Jasmine Love

Don’t give up on thiazides for #kidneystone prevention! We addressed concerns about the design of the thiazide trial that made us skeptical about the conclusions.

Rainbow cassette- what a way to celebrate #Pride!

About 10% of people in the U.S. will have a kidney stone at some point in their lives. NBC News nbcnews.com/health/kids-he…

ESWL vs URS in paediatric stones. Gregory Tasian, MD, MSc, MSCE reporting comparative multi centre (n=30) study. Key recommendations to use ESWL over URS for stones <10mm; for 10-15mm URS more effective but worse pt experience. Implications for guidelines ? #AUA24

Gregory Tasian, MD, MSc, MSCE presenting paradigm shifting work on behalf of PKIDS SWL v URS in children, 30 sites / 126 surgeons. >1200 pts representative of Peds population. Stone clearance : URS = SWL (strongest conclusion for stones < 10mm) PROs: SWL is BETTER #AUA2024